Your browser doesn't support javascript.
loading
Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A Feasibility Study.
Ho, Joanne Man-Wai; To, Eric; Sammy, Rebecca; Stoian, Matei; Tung, Jennifer Man-Han; Bodkin, Robert Jack; Cox, Lindsay; Antoniou, Tony; Benjamin, Sophiya.
Afiliação
  • Ho JM; Department of Medicine, McMaster University, Waterloo, ON, Canada. joanneho@mcmaster.ca.
  • To E; Schlegel Research Institute for Aging, Waterloo, ON, Canada. joanneho@mcmaster.ca.
  • Sammy R; GeriMedRisk, Waterloo, ON, Canada. joanneho@mcmaster.ca.
  • Stoian M; Department of Medicine, McMaster University, Waterloo, ON, Canada.
  • Tung JM; Department of Medicine, Western University, London, ON, Canada.
  • Bodkin RJ; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Cox L; Department of Family Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Antoniou T; Department of Pharmacy, Grand River Hospital, Kitchener, ON, Canada.
  • Benjamin S; GeriMedRisk, Waterloo, ON, Canada.
Drugs Real World Outcomes ; 11(1): 117-124, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38007818
ABSTRACT

BACKGROUND:

Adverse drug events among older adults result in significant mortality, morbidity and cost. This harm may be mitigated with appropriate prescribing and deprescribing. We sought to understand the prescribing outcomes of an interdisciplinary geriatric virtual consultation service.

METHODS:

We conducted a retrospective, before-and-after feasibility study to measure prescribing outcomes for a medication optimization virtual interdisciplinary geriatric specialist (MOVING) programme comprised of expertise from geriatric clinical pharmacology, pharmacy and psychiatry for older adults (aged ≥ 65 years) between June and December 2018, Ontario, Canada. The primary outcome was the number of distinct prescriptions and the presence of polypharmacy (defined as ≥ 4 medications) before and after the service. Secondary outcomes included the number of as needed and regularly administered prescriptions, number of potentially inappropriate prescriptions as defined by the Beers and STOPP criteria, and number of prescriptions for psychotropics, long-acting opioids and diabetic medications.

RESULTS:

We studied 40 patients with a mean age of 80.6 [standard deviation (SD) 8.8] years who received a MOVING consult. We found no significant change in the mean total number of prescriptions per patient before (12.02, SD 5.83) and after the intervention (11.58, SD 5.28), with a mean difference of -0.45 [95% confidence interval (CI) -0.94 to 0.04; p = 0.07]. We found statistically significant decreases in as needed prescriptions (mean difference - 0.30, 95% CI - 0.45 to - 0.15; p<0.001), and potentially harmful medications as identified by the Beers (mean difference -1.25, 95% CI -2.00 to -0.50; p = 0.002) and STOPP (mean difference -1.65, 95% CI -2.33 to -0.97; p < 0.001) scores. Without including the cost savings from hospital diversion by a MOVING consult, the costs of a MOVING consult were $545.80-$629.80 per person, compared with the costs associated with traditional in-person consults involving similar specialist clinical services ($904.89-$1270.69 per person).

CONCLUSION:

A MOVING model of care is associated with decreases in prescriptions for potentially inappropriate medications in older adults. These findings support further evaluation to ascertain health system impacts.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article